Dilantin (phenytoin) is a prescription drug used for certain types of seizures. Dilantin comes as a liquid suspension, oral capsule, and chewable tablet. Your dosage may vary based on certain factors, ...

On 7 June 2017, the Competition Appeal Tribunal (“CAT”) set aside parts of the Competition & Market Authority’s (“CMA”) decision in relation to the CMA’s finding that Pfizer and Flynn charged ...

Marketed formulations of extended phenytoin sodium -- long a difficult medication to titrate because of its unique absorption and saturable elimination pharmacokinetics -- may not be bioequivalent, ...

Britain’s competition watchdog has fined Pfizer a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and ...

Britain's competition watchdog has fined a record 84.2 million pounds ($107 million) for its role in ramping up the cost of an epilepsy drug by as much as 2,600 percent. The Competition and Markets ...

The US Food and Drug Administration (US FDA) has given its approval to Lupin to market 100 mg dosage of extended phenytoin sodium capsules, the pharmaceutical company said in a press release. The anti ...

The Competition and Markets Authority also fined Flynn Pharma 5.2 million pounds for its role in hiking prices of phenytoin sodium capsules in 2012. Advisory Alert: It has come to our attention that ...

Phenytoin (Dilantin) is an anticonvulsant, prescribed for certain types of seizures (eg, status epilepticus). It decreases abnormal electrical activity in the brain. The information provided on this ...

US pharma giant Pfizer and a partnering distributor have been slapped with a record fine for hiking UK drug prices by 2,600% overnight. In September 2012, the amount the National Health Service (NHS) ...

Epilepsy is a short neurological disorder in which subsequent seizures are caused by increasing electrical discharges from the availability. Worldwide, phenytoin and carbamazepine are generally used ...

Two pharmaceutical companies have been fined a total of almost £70 million for overcharging the NHS for epilepsy drug phenytoin sodium. Pfizer was fined £63 million and Flynn Pharma £6.7 million after ...